PTH and osteoporosis: Among them, teriparatide (TRP), a 1–34 amino acid fragment of recombinant human parathyroid hormone [PTH (1-34)], was the only anabolic agent approved by the Food and Drug Administration (FDA) for the treatment of osteoporosis [11,12].